Evolus, Inc. Common Stock - stock earnings
EOLS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -11.8 million USD | 61.0 million USD |
| 2023Q3 | -16.9 million USD | 49.3 million USD |
| 2023Q2 | -18.1 million USD | 49.3 million USD |
| 2023Q1 | -14.8 million USD | 41.7 million USD |
| 2022Q4 | -13.2 million USD | 43.6 million USD |
| 2022Q3 | -20.3 million USD | 33.9 million USD |
| 2022Q2 | -23.5 million USD | 37.2 million USD |
| 2022Q1 | -17.5 million USD | 33.9 million USD |
| 2021Q4 | -18.2 million USD | 34.7 million USD |
| 2021Q3 | -19.4 million USD | 26.7 million USD |
| 2021Q2 | -15.6 million USD | 26.1 million USD |
| 2021Q1 | 6.4 million USD | 12.2 million USD |
| 2020Q4 | -110.7 million USD | 20.6 million USD |
| 2020Q3 | -11.5 million USD | 17.7 million USD |
| 2020Q2 | -21.1 million USD | 7.8 million USD |
| 2020Q1 | -19.7 million USD | 10.5 million USD |
| 2019Q4 | -14.5 million USD | 19.4 million USD |
| 2019Q3 | -27.0 million USD | 13.2 million USD |
| 2019Q2 | -37.6 million USD | 2.3 million USD |
| 2019Q1 | -11.0 million USD | ? USD |
| 2018Q4 | -12.4 million USD | ? USD |
| 2018Q3 | -11.8 million USD | ? USD |
| 2018Q2 | -16.4 million USD | ? USD |
| 2018Q1 | -6.2 million USD | ? USD |
| 2017Q4 | 4.4 million USD | ? USD |
| 2017Q3 | -2.6 million USD | ? USD |
| 2017Q2 | -2.3 million USD | ? USD |
| 2017Q1 | -4.0 million USD | ? USD |
| 2016Q4 | -3.7 million USD | ? USD |
| 2015Q4 | -31.1 million USD | ? USD |
EOLS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.7 million USD | 202.1 million USD |
| 2022 | -74.4 million USD | 148.6 million USD |
| 2021 | -46.8 million USD | 99.7 million USD |
| 2020 | -163.0 million USD | 56.5 million USD |
| 2019 | -90.0 million USD | 34.9 million USD |
| 2018 | -46.9 million USD | ? USD |
| 2017 | -4.5 million USD | ? USD |
| 2016 | -20.1 million USD | ? USD |
| 2015 | -31.1 million USD | ? USD |
EOLS
Price: $13.22
52 week price:
Earnings Per Share: -1.08 USD
P/E Ratio: -12.23
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 16622
Market Capitalization: 815.5 million